Hopital du Valais
Sion, 1950, Switzerland
NCT Number: NCT03957772
Patients will be randomized to one of two groups:
1. Extrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the exterior of the fascial sheath that surrounds the nerves 2. Intrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the interior of the fascial sheath that surrounds the nerves
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Phase 4
Sion, 1950, Switzerland
The study will be proposed to all patients undergoing formarm or hand surgery under axillary brachial plexus block. Patients will be randomized to one of two groups.
The first group - extrafascial injection group - will receive an ultrasound-guided supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the exterior of the fascial sheath that surrounds the nerves.
The second group - intrafascial injection group - will receive an ultrasound-guided supraclavicular brachial plexus block whereby the local anesthetic will be deposited at the interior of the fascial sheath that surrounds the nerves.
All patients will receive the same type and amount of local anesthetic: 30 ml of a mixture of ropivacaine 0.5 % + mepivacaine 1 %.
The primary outcome is the rate of hemidiaphragmatic paresis 30 minutes after the block procedure, assessed with ultrasound. Secondary outcomes are: rate of hemidiaphragmatic paresis 2 hours after surgery, assessed with ultrasound, bedside spirometry before the supraclavicular block, 30 minutes after the block and 2 hours after surgery, rate of successful block 30 minutes after the block , duration of sensory and motor block, pain scores at rest and on movement at 24 h postoperatively, cumulative postoperative opioid consumption at 24 hours postoperatively and patient satisfaction with overall anesthetic management.
These outcomes are further defined in the section below.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Extrafascial injection of local anaesthetic under ultrasound guidance
Intrafascial injection of local anaesthetic under ultrasound guidance
Time frame: 30 minutes after the block
Rate of hemidiaphragmatic paresis 30 minutes after the block procedure, assessed with ultrasound
Time frame: 2 hours after surgery
Rate of hemidiaphragmatic paresis 2 hours after surgery, assessed with ultrasound
Time frame: 30 minutes before the block
Bedside spirometry before the supraclavicular block
Time frame: 30 minutes after the supraclavicular block
Bedside spirometry after the supraclavicular block
Time frame: 2 hours after surgery
Bedside spirometry 2 hours after surgery
Time frame: 30 minutes after the block
Presence of a surgical block according to a validated composite scale
Time frame: 24 h postoperatively
paresthesia, dyspnea, Horner's syndrome, hoarseness, hematoma, infection
Time frame: During block procedure
Pain score (numeric rating scale, 0-10, with 0=no pain, 10=worst imaginable pain)
Time frame: 24 h postoperatively
Pain score (numeric rating scale, 0-10, with 0=no pain, 10=worst imaginable pain)
Time frame: 24 hours postoperatively
Cumulative postoperative opioid consumption
Time frame: 24 hours postoperatively
numeric rating scale, 0-10)
Hôpital du Valais
Other
The Efficacy of Extra- Versus Intrafascial Injection for Supraclavicular Brachial Plexus Block: a Randomized Controlled, Single-blinded Trial
Acronym: SUPRA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05799391
Upper Extremity Problem
Hong Kong
View Trial DetailsNCT06366633
Chemically-Induced Disorders, Chronic Pain
Boston, Massachusetts, United States
View Trial DetailsNCT06278740
Central Nervous System Diseases, Muscular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT05980078
Upper Extremity Problem
Austin, Texas, United States
View Trial Details